ADCT
Price
$1.72
Change
-$0.12 (-6.52%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
167.27M
2 days until earnings call
NMRA
Price
$1.33
Change
-$0.15 (-10.07%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
241.35M
63 days until earnings call
Ad is loading...

ADCT vs NMRA

Header iconADCT vs NMRA Comparison
Open Charts ADCT vs NMRABanner chart's image
ADC Therapeutics SA
Price$1.72
Change-$0.12 (-6.52%)
Volume$4.03K
Capitalization167.27M
Neumora Therapeutics
Price$1.33
Change-$0.15 (-10.07%)
Volume$5.05K
Capitalization241.35M
ADCT vs NMRA Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. NMRA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and NMRA is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ADCT: $1.84 vs. NMRA: $1.49)
Brand notoriety: ADCT and NMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 69% vs. NMRA: 34%
Market capitalization -- ADCT: $167.27M vs. NMRA: $241.35M
ADCT [@Biotechnology] is valued at $167.27M. NMRA’s [@Biotechnology] market capitalization is $241.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileNMRA’s FA Score has 1 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • NMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ADCT is a better buy in the long-term than NMRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while NMRA’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 4 bearish.
  • NMRA’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, NMRA is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а +4.55% price change this week, while NMRA (@Biotechnology) price change was -4.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

ADCT is expected to report earnings on May 12, 2025.

NMRA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NMRA($241M) has a higher market cap than ADCT($167M). ADCT YTD gains are higher at: -7.538 vs. NMRA (-85.943). ADCT has higher annual earnings (EBITDA): -110.43M vs. NMRA (-313.91M). NMRA has more cash in the bank: 341M vs. ADCT (274M). NMRA has less debt than ADCT: NMRA (2.75M) vs ADCT (125M). ADCT has higher revenues than NMRA: ADCT (70.7M) vs NMRA (0).
ADCTNMRAADCT / NMRA
Capitalization167M241M69%
EBITDA-110.43M-313.91M35%
Gain YTD-7.538-85.9439%
P/E RatioN/AN/A-
Revenue70.7M0-
Total Cash274M341M80%
Total Debt125M2.75M4,554%
TECHNICAL ANALYSIS
Technical Analysis
ADCTNMRA
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
90%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
54%
View a ticker or compare two or three
Ad is loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYPX30.970.16
+0.52%
American Beacon Man Lg Cp Growth Inv
TEQPX11.390.05
+0.44%
Nuveen Emerging Markets Eq Idx Prem
WGUSX14.500.04
+0.28%
Wasatch US Select Inst
GTSDX8.27N/A
N/A
Invesco Small Cap Growth C
VCGRX21.43-0.03
-0.14%
Virtus KAR Capital Growth R6

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+5.14%
CLRB - ADCT
46%
Loosely correlated
+3.79%
ANAB - ADCT
41%
Loosely correlated
-0.37%
AURA - ADCT
39%
Loosely correlated
-0.94%
ARVN - ADCT
39%
Loosely correlated
+1.22%
TSVT - ADCT
38%
Loosely correlated
-6.99%
More

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with NGNE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
-1.97%
NGNE - NMRA
38%
Loosely correlated
+3.16%
ABOS - NMRA
37%
Loosely correlated
+0.81%
AURA - NMRA
36%
Loosely correlated
-0.94%
SNDX - NMRA
35%
Loosely correlated
-6.09%
INZY - NMRA
34%
Loosely correlated
-6.50%
More